OABCAPProject reference: 663530
Funded under :
H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being
Demonstration of a new diagnostic device for the Overactive Bladder syndrome
Total cost:EUR 71 429
EU contribution:EUR 50 000
Topic(s):PHC-12-2014-1 - Clinical research for the validation of biomarkers and/or diagnostic medical devices
Call for proposal:H2020-SMEINST-1-2014See other projects for this call
Funding scheme:SME-1 - SME instrument phase 1
ALBYN MEDICAL has developed, in cooperation with the Chemnitz University of Technology and the University Hospital of Cologne (Germany), a specific diagnostic system for the Overactive Bladder syndrome. This diagnostic device is implanted by cystoscopy and measures the bladder pressure autonomously, relating the bladder pressure with the urination, controlled or not, and it determines if the pressure rise appears only when a voluntary urination occurs or if also occurs other times as in the accidental urine loss.
Thanks to the new diagnostic device a reliable diagnostic evaluation is obtained and thus high treatment costs of the current Overactive Bladder over-diagnosis are avoided improving the sustainability of the European Health and Care systems.
EU contribution: EUR 50 000
Poligono Industrial de Cordovilla D1